2-(1-(2,4-dimethylphenyl)-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-3-yl)-5-(trifluoromethyl)phenol

ID: ALA5193453

PubChem CID: 168290133

Max Phase: Preclinical

Molecular Formula: C23H18F3N3O2

Molecular Weight: 425.41

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(-n2nc(-c3ccc(C(F)(F)F)cc3O)nc2-c2ccccc2O)c(C)c1

Standard InChI:  InChI=1S/C23H18F3N3O2/c1-13-7-10-18(14(2)11-13)29-22(17-5-3-4-6-19(17)30)27-21(28-29)16-9-8-15(12-20(16)31)23(24,25)26/h3-12,30-31H,1-2H3

Standard InChI Key:  SLVBCQMKRKBIFO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0844   -0.8269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5829   -0.3420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3280    0.4426    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4970    0.4426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7519   -0.3420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9095    1.1572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4971    1.8720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9091    2.5841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7345    2.5841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1464    1.8738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7382    1.1572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1471    3.2988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9723    3.2988    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1471    4.1255    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.4325    3.7113    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3280    1.8720    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3800   -0.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5938   -1.3526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3887   -1.5648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9723   -0.9812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7613   -0.1876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9660    0.0304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7524    0.8274    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0844   -1.6521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7989   -2.0649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7982   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0834   -3.3003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6284   -2.8911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6332   -2.0664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5136   -1.6523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0834   -4.1255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  6  4  1  0
  7  6  2  0
  8  7  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
  6 11  1  0
  9 12  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
  7 16  1  0
 17  2  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
 22 23  1  0
 24  1  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 28 27  1  0
 29 28  2  0
 24 29  1  0
 25 30  1  0
 27 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5193453

    ---

Associated Targets(Human)

HaCaT (4069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PC-12 (7051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.41Molecular Weight (Monoisotopic): 425.1351AlogP: 5.65#Rotatable Bonds: 3
Polar Surface Area: 71.17Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.61CX Basic pKa: CX LogP: 7.05CX LogD: 6.84
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.45Np Likeness Score: -1.11

References

1. Lao Y, Wang Y, Chen J, Huang P, Su R, Shi J, Jiang C, Zhang J..  (2022)  Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.,  236  [PMID:35390713] [10.1016/j.ejmech.2022.114315]

Source